🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey Girshman

New York Oncology Hematology

ORCID: 0000-0003-0533-0423
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.3Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0580
Top 16%
1.3DataRank
Top 16%36 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +24 more

Papers

Driven by 17 papers — median percentile 0. Top paper: “Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study”.

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3
N/A
4.7DataRank · unranked
264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0580
Top 16%
1.3DataRank
Top 16%36 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +24 more

Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0419
N/A
0.635DataRank · unranked
68 citations

Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J. Plodkowski, Mustafa Sakhi +11 more

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.087
N/A
0.385DataRank · unranked
12 citations

Sushmita Gordhandas, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman +12 more

Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101638
N/A
0.276DataRank · unranked
4 citations

Kay J. Park, Simran Makker, Jeffrey Girshman, Carol Aghajanian, Rachel N. Grisham +1 more

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026
N/A
0.269DataRank · unranked
5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer

medRxiv(2024)10.1101/2024.06.07.24308618
N/A
0.104DataRank · unranked
1 citations

Eduardo Ortiz, Caroline S. Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman +10 more

Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?

Clinical Imaging(2020)10.1016/j.clinimag.2020.07.005
N/A
0.104DataRank · unranked
1 citations

José de Arimateia Batista Araújo-Filho, Cameron D. A. Simmers, Jeffrey Girshman, Micheal Raj, Junting Zheng +3 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700.v1
Top 100%
0DataRank
Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700
Top 100%
0DataRank
Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer

Journal of Clinical Investigation(2024)10.1172/jci180516
N/A
0DataRank · unranked
19 citations

Eduardo Ortiz, Caroline S. Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman +10 more

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.015
N/A
0DataRank · unranked
17 citations

Charlie White, Alexia Iasonos, Pier Selenica, Oliver Zivanovic, S. Dennis +7 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005
N/A
0DataRank · unranked
3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

Computational biomarker predicts lung ICI response via deep learning-driven hierarchical spatial modelling from H&E

Research Square(2022)10.21203/rs.3.rs-1251762/v1
N/A
0DataRank · unranked
8 citations

Chad Vanderbilt, Chao Feng, David Joon Ho, Gabrielle Campanella, Jacklynn V. Egger +7 more

Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study

Clinical Imaging(2020)10.1016/j.clinimag.2020.10.052
N/A
0DataRank · unranked
4 citations

Andrew J. Plodkowski, Jeffrey Girshman, Debra Sarasohn, A. Viteri, Sumar Hayan +2 more

Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer

Lung Cancer(2021)10.1016/j.lungcan.2021.08.020
N/A
0DataRank · unranked
5 citations

Andrew Pagano, Andrew J. Plodkowski, Jeffrey Girshman, Matthew D. Hellmann, Hira Rizvi +6 more

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Cancer(2023)10.1002/cncr.34753
N/A
0DataRank · unranked
19 citations

Ryan Kahn, David Nemirovsky, Jeffrey Girshman, Anya Laibangyang, Sushmita Gordhandas +8 more